Combination of oxymatrine sensitizes hemangioma cells to the propranolol response by inducing AMBRA1/PINK1/PRKN-mediated mitophagy
Approximately 10% of infantile hemangioma (IH) patients exhibit a suboptimal response to propranolol (PRN) therapy, necessitating alternative strategies to enhance its therapeutic efficacy. Female BALB/c nude mice were used to establish a xenograft model of IH and randomized into four groups (Saline, OMT alone, PRN alone, and PRN/OMT combination). EOMA cells were used as an in vitro IH model. Key proteins mediating the synergistic effect of the PRN/OMT combination were identified via proteomic analysis, followed by experimental validation. Compared with PRN alone, the combination of PRN/OMT induced a more pronounced antitumor effect in IH mice. In EOMA cells, OMT markedly decreased the IC50 of PRN. Moreover, the combination of PRN/OMT induced more severe mitochondrial damage, leading to a higher proportion of apoptotic cells. Furthermore, proteomic analysis identified AMBRA1 as one of the key differentially expressed proteins (DEPs) associated with PINK1/PRKN-mediated mitophagy that may contribute to the synergistic effect of the PRN/OMT combination. Notably, the synergistic effect of the PRN/OMT combination was significantly abrogated by either AMBRA1 knockdown or pretreatment with Mdivi-1 (a mitochondrial fission inhibitor). Mechanistically, aberrant AMBRA1 expression was regulated by PRN and OMT through distinct mechanisms: PRN was involved in the transcriptional activation of AMBRA1, whereas OMT was responsible for promoting AMBRA1 protein translation. This study revealed a synergistic effect of the PRN/OMT combination on hemangiomas, which could enhance the therapeutic efficacy of PRN therapy by inducing excessive mitophagy.
Authors
- Junkai Yan (ORCID: https://orcid.org/0000-0001-6593-9279)
- Mingke Qiu
- Jingmin Ou
- Shuqing Wang
- Jingyu Peng
- Yuxin Dai
- Changqing Ouyang
- Yang Wang
Institutions
- Shanghai Jiao Tong University (CN)
- XinHua Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1007/s12672-026-06294-1
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China